5,7-dihydroxytryptamine has been researched along with Cognition Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertrand, F; Cassel, JC; Jeltsch, H; Lazarus, C; Lehmann, O; Morer, M; Will, B | 1 |
1 other study(ies) available for 5,7-dihydroxytryptamine and Cognition Disorders
Article | Year |
---|---|
5,7-DHT-induced hippocampal 5-HT depletion attenuates behavioural deficits produced by 192 IgG-saporin lesions of septal cholinergic neurons in the rat.
Topics: 5,7-Dihydroxytryptamine; Acetylcholine; Acetylcholinesterase; Animals; Antibodies, Monoclonal; Behavior, Animal; Cholinergic Agents; Cognition Disorders; Denervation; Drug Interactions; Hippocampus; Immunotoxins; Male; Maze Learning; Motor Activity; N-Glycosyl Hydrolases; Neural Pathways; Neurons; Postural Balance; Raphe Nuclei; Rats; Rats, Long-Evans; Ribosome Inactivating Proteins, Type 1; Saporins; Septal Nuclei; Serotonin; Serotonin Agents | 2002 |